Despite a higher incidence of adverse events, gilteritinib was not associated with any patient-reported impact of side effects. BMT CTN 1506
Avoid combination. Gilteritinib: Escitalopram may enhance the QTc-prolonging effect of Gilteritinib. Gilteritinib may diminish the therapeutic effect of Escitalopram. Management: Avoid use of this combination if possible. If use is necessary, monitor for reduced response to escitalopram and for QTc prolongation and arrhythmias.
The most common severe side effects for those in the gilteritinib group were fever with reduction of certain white blood cells, anemia, and low platelet count. Approximately 11% of patients taking gilteritinib stopped taking it because of side effects.
The most common severe side effects for those in the gilteritinib Approximately 11% of patients taking gilteritinib stopped taking it because
There are no data on the effect of gilteritinib on human fertility. Gilteritinib has minor influence on the ability to drive and use machines. Dizziness has
effects on the pharmacokinetics of gilteritinib During Xospata treatment, you may also have side effects of abnormal blood test results (very
side effects. Although we're waiting for the final analysis of ADMIRAL, the available data with gilteritinib show fewer and milder side effects
A causality assessment was performed according to the Dx3 method to evaluate the possibility that ICHs might be an actual side effect of gilteritinib. In conclusion, further research is needed to elucidate the potential role of gilteritinib in the pathogenesis of ICHs.
The three most common side effects attributed to gilteritinib were diarrhea in 41 patients (16 percent), fatigue in 37 (15 percent), and
Comments
one of my own pet peeves, sorry